Malaria P. Vivax Quantitative Test
At DNA Labs UAE, we offer the Malaria P. Vivax Quantitative Test at a cost of AED 1020.0. This test is used to determine the amount of Plasmodium vivax parasites present in a patient’s blood.
Test Details
The Malaria P. Vivax Quantitative Test is a diagnostic test used to quantify the number of P. vivax parasites in a patient’s blood. This test is particularly useful in monitoring the effectiveness of antimalarial treatment and determining if the infection has been fully cleared from the patient’s system.
The test involves collecting a blood sample from the patient and using various laboratory techniques, including Real Time PCR, to quantify the number of P. vivax parasites in the sample. The results are reported as the number of parasites per microliter (L) of blood.
Symptoms and Diagnosis
Plasmodium vivax is a species of parasite that causes malaria, a potentially life-threatening disease. Common symptoms of P. vivax malaria include fever, chills, headache, muscle pain, and fatigue. If you are experiencing these symptoms, it is important to consult a physician for diagnosis and treatment.
Prior to the Malaria P. Vivax Quantitative Test, patients are required to sign a Consent document and bring any clinical history related to Malaria (P. Vivax). This information helps healthcare professionals assess the severity of the infection and guide treatment decisions.
Report Delivery
After the blood sample is collected, the test results are typically delivered within 3 working days via email (within 36 hours) or over the phone (within 24 hours).
Test Department and Doctor
The Malaria P. Vivax Quantitative Test is performed in our Genetics department by skilled technicians or medical professionals under the supervision of a physician.
Conclusion
The Malaria P. Vivax Quantitative Test offered by DNA Labs UAE is a valuable tool in the diagnosis and management of P. vivax malaria. It allows healthcare professionals to accurately assess the parasite load in patients and guide appropriate treatment strategies. If you are experiencing symptoms of malaria or need to monitor the effectiveness of your antimalarial treatment, consider getting tested with us.
Test Name | Malaria P. Vivax Quantitative Test |
---|---|
Components | |
Price | 1020.0 AED |
Sample Condition | Whole Blood,dried spot. |
Report Delivery | 3rd Working Day Email:-36 hours. On phone: 24 hours |
Method | Real Time PCR |
Test type | Viral |
Doctor | Physician |
Test Department: | Genetics |
Pre Test Information | Need to sign Consent document and bring any clinical history of patient forMalaria (P. Vivax) QuantitativeTest |
Test Details |
The Malaria (P. Vivax) Quantitative Test is a diagnostic test used to determine the amount of Plasmodium vivax parasites present in a patient’s blood. Plasmodium vivax is a species of parasite that causes malaria, a potentially life-threatening disease. The test involves collecting a blood sample from the patient and then using various laboratory techniques to quantify the number of P. vivax parasites in the sample. This can help healthcare professionals assess the severity of the infection and guide treatment decisions. The Malaria (P. Vivax) Quantitative Test is typically performed in a laboratory setting by skilled technicians or medical professionals. The results of the test are usually reported as the number of parasites per microliter (L) of blood. This quantitative test is particularly useful in monitoring the effectiveness of antimalarial treatment and determining if the infection has been fully cleared from the patient’s system. It can also help in identifying relapses or reinfections in patients who have previously been treated for P. vivax malaria. It’s important to note that this test specifically targets P. vivax, and not other species of malaria-causing parasites such as Plasmodium falciparum or Plasmodium malariae. Different diagnostic tests may be required to identify and quantify these other species. Overall, the Malaria (P. Vivax) Quantitative Test is a valuable tool in the diagnosis and management of P. vivax malaria, allowing healthcare professionals to accurately assess the parasite load in patients and guide appropriate treatment strategies. |